Procalcitonin - A marker of invasive fungal infection?

Supportive Care in Cancer

Volumn 13, Issue 5, 2005, Pages 343-346

  Dornbusch, H J ^a   Strenger, V ^a   Kerbl, R ^a   Lackner, H ^a   Schwinger, W ^a   Sovinz, P ^a   Urban, C ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Aspergillosis; Candidiasis; Invasive fungal infection; Marker; Procalcitonin

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; PREDNISOLONE; PROCALCITONIN;

ADOLESCENT; ARTICLE; ASPERGILLUS; BLOOD SAMPLING; CANDIDA; CANDIDIASIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE MARKER; FEMALE; GRANULOCYTE; HUMAN; LUNG ASPERGILLOSIS; MALE; MYCOSIS; PRIORITY JOURNAL; PROBABILITY; RELIABILITY; SCHOOL CHILD; SENSITIVITY ANALYSIS; SPUTUM ANALYSIS;

ADOLESCENT; ASPERGILLOSIS; AUSTRIA; BIOLOGICAL MARKERS; CALCITONIN; CANDIDA ALBICANS; CANDIDIASIS; CHILD; FEMALE; FUNGEMIA; HUMANS; MALE; PROTEIN PRECURSORS;

EID: 18744401350     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-004-0721-3     Document Type: Article

References (18)

1. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ, on behalf of the Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases (2002) Defining opportunistic invasive fungal infections in immuno-compromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34(1):7-14
2. Beaune G, Bienvenu F, Pondarre C, Monneret G, Bienvenu J, Souillet G (1998) Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis. Infection 26(3):168-169
3. Blijlevens NM, Donnelly JP, Meis JF, De Keizer MH, De Pauw BE (2000) Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 7(6):889-892
4. Christofilopoulou S, Charvalos E, Petrikkos G (2002) Could procalcitonin be a predictive biological marker in systemic fungal infections? Study of 14 cases. Eur J Intern Med 13(8):493-495
5. Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, Begue RJ, Piette JC, Aumaitre O (2003) Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 62(4):337-340
6. Eloy O, Vauloup C, Therond P, Pina P, Allouch P, Pangon B, Bedos J-P, Ghnassia J-C (2001) Intérêt du dosage de la procalcitonine dans les infections profondes fongique à Candida. Ann Biol Clin 59(4):502-505
7. Fleischhack G, Cipic D, Juettner J, Hasan C, Bode U (2000) Procalcitonin - a sensitive inflammation marker of febrile episodes in neutropenic children with cancer. Intensive Care Med 26 [Suppl 2]:S202-S211
8. Gerard Y, Hober D, Petitjean S, Assicot M, Bohoun C, Mouton Y, Wattre P (1995) High serum procalcitonin level in a 4-year-old liver transplant recipient with disseminated candidiasis. Infection 23(5):310-311
9. Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H (2001) Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 32:1718-1724
10. Hambach L, Eder M, Dammann E, Schrauder A, Sykora K-W, Dieterich C, Kirschner P, Novotny J, Ganser A, Hertenstein B (2002) Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. Haematologica 87(6):643-651
11. Huber W, Schweigart U, Bottermann P (1997) Failure of PCT to indicate severe fungal infection in two immunodeficient patients. Infection 25(6):377-378
12. Jantunen E, Piilonen A, Volin L, Parkkali T, Koukila- Kähkölä P, Ruutu T, Ruutu P (2000) Diagnostic aspects of invasive aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 25:867-871
13. Karzai W, Meier-Hellmann H, Reinhart K (1998) Procalcitonin - an indicator of sepsis. In: Vincent J-L (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 247-256
14. Oczenski W, Fitzgerald RD, Schwarz S (1998) Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period. Eur J Anaesthesiol 15:202-209
15. Pahlke K, Oberhoffer M, Karzai W, Meier-Hellmann A, Reinhart K (1997) Procalcitonin - features of a new parameter in severe bacterial infections and sepsis. Intensivmed 34:381-387
16. Rau B, Steinbach G, Gansauge F, Mayer JM, Grünert A, Beger HG (1997) The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 41(6):832-840
17. Svaldi M, Hirber J, Lanthaler AI, Mayr O, Faes S, Peer E, Mitterer M (2001) Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 115(1):53-57
18. von Heimburg D, Stieghorst W, Khorram-Sefat R, Pallua N (1998) Procalcitonin - a sepsis parameter in severe burn injuries. Burns 24(8):745-750